Simplex Trading
AXSM icon

Simplex Trading’s Axsome Therapeutics AXSM Stock Holding History

Simplex Trading’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$642K Sell
3,800
-20,900
-85% -$3.61M ﹤0.01% 2978
2025
Q4 		$4.51M Buy
24,700
+2,600
+12% +$363K ﹤0.01% 1353
2025
Q3 		$2.68M Sell
22,100
-15,500
-41% -$1.75M ﹤0.01% 2023
2025
Q2 		$3.92M Buy
37,600
+16,500
+78% +$1.75M ﹤0.01% 1551
2025
Q1 		$2.46M Sell
21,100
-109,400
-84% -$12.5M ﹤0.01% 1854
2024
Q4 		$11M Buy
130,500
+31,400
+32% +$2.89M 0.01% 963
2024
Q3 		$8.91M Buy
99,100
+72,700
+275% +$6.35M 0.01% 1107
2024
Q2 		$2.13M Sell
26,400
-2,200
-8% -$163K ﹤0.01% 2143
2024
Q1 		$2.28M Buy
28,600
+11,300
+65% +$948K ﹤0.01% 2272
2023
Q4 		$1.38M Buy
17,300
+4,600
+36% +$308K ﹤0.01% 2706
2023
Q3 		$887K Sell
12,700
-39,100
-75% -$2.92M ﹤0.01% 2794
2023
Q2 		$3.72M Sell
51,800
-21,300
-29% -$1.57M ﹤0.01% 1516
2023
Q1 		$4.51M Sell
73,100
-24,000
-25% -$1.58M ﹤0.01% 1365
2022
Q4 		$7.49M Sell
97,100
-16,700
-15% -$998K 0.01% 991
2022
Q3 		$5.08M Sell
113,800
-93,900
-45% -$4.69M 0.01% 1198
2022
Q2 		$7.95M Buy
207,700
+148,200
+249% +$4.69M 0.01% 900
2022
Q1 		$2.46M Buy
59,500
+41,800
+236% +$1.3M ﹤0.01% 1891
2021
Q4 		$668K Buy
17,700
+16,200
+1,080% +$596K ﹤0.01% 3423
2021
Q3 		$102K Hold
1,500
– – ﹤0.01% 6592
2021
Q2 		$101K Buy
1,500
+1,470
+4,900% +$88.2K ﹤0.01% 6712
2021
Q1 		$169K Buy
+30
New +$2.11K ﹤0.01% 5005
2020
Q2 		– Sell
-727
Closed -$4.28M – 7585
2020
Q1 		$4.28M Sell
727
-275
-27% -$22.4K 0.01% 780
2019
Q4 		$10.4M Buy
1,002
+628
+168% +$25.4K 0.02% 451
2019
Q3 		$756K Buy
374
+17
+5% +$437 ﹤0.01% 2219
2019
Q2 		$919K Sell
357
-703
-66% -$14.1K ﹤0.01% 1980
2019
Q1 		$1.51M Buy
1,060
+1,056
+26,400% +$9.8K ﹤0.01% 1625
2018
Q4 		$1K Buy
+4
New +$13 ﹤0.01% 6704

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's AXSM Position: Q1 2026 in Review

Simplex Trading sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 25,222 shares — an estimated $4.36M sold.

Simplex Trading first reported a position in AXSM in Q3 2018 and held it in 28 quarters. The position peaked at $4.61M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Simplex Trading reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 25,222 Axsome Therapeutics shares in Q1 2026, an estimated $4.36M.
  • Simplex Trading first reported a position in Axsome Therapeutics in Q3 2018 and held it in 28 quarters.
  • Simplex Trading's Axsome Therapeutics position peaked at $4.61M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.